Indian-origin woman given months to remain cancer-free after drug trial in UK

Indian-origin woman given months to remain cancer-free after drug trial in UK

The woman said that she is looking forward to celebrating her 25th wedding anniversary.

London:

An Indian-origin woman who was given a few months to live a few years ago is celebrating on Monday after doctors said clinical trials at a UK hospital showed no evidence of breast cancer.

Jasmine David, 51, of Felfield, Manchester, is now hoping to celebrate her 25th wedding anniversary in September after a successful National Health Service (NHS) test.

Ms David’s two-year trial at the National Institute for Health and Care Research (NIHR) Manchester Clinical Research Facility (CRF) at the Christie NHS Foundation Trust involved an experimental drug combined with atezolizumab, an immunotherapy drug administered intravenously. administered, which she continues every three. Week.

“I was 15 months down the line after my initial cancer treatment and almost forgot about it, but then the cancer came back,” recalls Ms. David.

“When I was offered the test, I didn’t know it would work for me, but I thought at least I could do something to help others and use my body for the next generation. Previously, I had a number of terrible side effects including headaches and a rising temperature, so I was in the hospital over Christmas and was pretty bad. Then thankfully I started responding well to treatment,” she said.

The already fit and healthy mother of two grown children worked as a clinical lead in a care home for the elderly.

She discovered she had an aggressive triple negative form of breast cancer in November 2017, when she found a lump above the nipple.

In April 2018, she underwent six months of chemotherapy and a mastectomy, followed by 15 cycles of radiotherapy to free her body of cancer.

Then the cancer returned in October 2019, and scans showed multiple lesions throughout her body, meaning she had a poor prognosis.

The cancer had spread to the lungs, lymph nodes and bone of the chest and she was given the devastating news that she had less than a year to live. Two months later, and with no other option left, David was offered the opportunity to be part of the research by participating in a Phase I clinical trial.

“I celebrated my 50th birthday in February 2020 while still in the middle of treatment and didn’t know what the future holds. Two and a half years ago I thought it was the end and I feel like I am reborn is,” she said.

“My life has taken a turn after returning from India to see family in April and I have decided to take early retirement and live my life in gratitude to God and medical science. My family has been very supportive of this decision. I am celebrating my 25th wedding anniversary in September. I have a lot to look forward to.”

“My Christian faith helped me a lot in this journey and the prayers and support of family and friends gave me the strength to face the challenge,” he said.

As of June 2021, scans showed no measurable cancer cells in her body and she was considered cancer-free. She will be on treatment till December 2023 but is showing no evidence of illness.

“We are really happy that Jasmine has had such a great outcome. At Christie’s we are constantly testing new drugs and treatments to see if they can benefit more people,” said Professor Fiona Thistlethwaite, Medical oncologist and clinical director of Manchester CRF. Christie.

(Except for the title, this story has not been edited by NDTV staff and is published from a syndicated feed.)

,

Indian Lekhak

Leave a Reply

Your email address will not be published.